Concepedia

Annika Nelde

AN

36

Publications

2.4K

Citations

26

H-Index

2007

Active since

Affiliations

University of Tübingen(Current)

Deutschen Konsortium für Translationale Krebsforschung

German Cancer Research Center

University Children's Hospital Tübingen

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology

Annika Nelde is an author at University of Tübingen specializing in immunology, medicine, and immunotherapy.

ORCID

Top concepts

Publications per year

2007–2024

36

Publications

36

SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition

Annika Nelde, Tatjana Bilich, Jonas S. Heitmann et al. · Nature Immunology · 2020 · 630 citations

, , +2

A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity

Jonas S. Heitmann, Tatjana Bilich, Claudia Tandler et al. · Nature · 2021 · 268 citations · Full text

T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals

Tatjana Bilich, Annika Nelde, Jonas S. Heitmann et al. · Science Translational Medicine · 2021 · 166 citations · Full text

The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell–based immunotherapy

Simon Walz, Juliane S. Stickel, Daniel J. Kowalewski et al. · Blood · 2015 · 107 citations · Full text

Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy

Anna Reustle, Moreno Di Marco, Carolin Meyerhoff et al. · Genome Medicine · 2020 · 101 citations · Full text

Rows per page

1–5 of 36